In search for other potential biomarkers for this type of osteoporosis we showed that both intact and C-terminal FGF23 were significantly elevated in WNT1 mutation-positive subjects, while concentrations of the two WNT pathway-associated markers Sclerostin and DKK1 did not differ from age-matched controls [76]. This evidence concerns the gene WNT1 and osteoporosis.